Cargando…
RNA-electroporated T cells for cancer immunotherapy
Adoptive T cell therapy has proven effective against hematologic malignancies and demonstrated efficacy against a variety of solid tumors in preclinical studies and clinical trials. Nonetheless, antitumor responses against solid tumors remain modest, highlighting the need to enhance the effectivenes...
Autores principales: | Pohl-Guimarães, Fernanda, Hoang-Minh, Lan B., Mitchell, Duane A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553534/ https://www.ncbi.nlm.nih.gov/pubmed/33101771 http://dx.doi.org/10.1080/2162402X.2020.1792625 |
Ejemplares similares
-
Electroporation and Immunotherapy—Unleashing the Abscopal Effect
por: Justesen, Tobias Freyberg, et al.
Publicado: (2022) -
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018) -
Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment
por: Gong, Xuan, et al.
Publicado: (2022) -
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
por: Pisani, Silvia, et al.
Publicado: (2022) -
Tracking adoptive T cell immunotherapy using magnetic particle imaging
por: Rivera-Rodriguez, Angelie, et al.
Publicado: (2021)